Ulrich Ebbinghaus-Kintscher

This inventor holds 19 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 15 EPO patents, primarily in Pesticide Chemistry. Top assignees: Bayer Aktiengesellschaft, Bayer Cropscience Ag, Elanco Animal Health Gmbh. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrich Ebbinghaus-Kintscher. Retrieved from https://idiyas.com/inventor/ulrich-ebbinghaus-kintscher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 18)

% Patents Active = 68.4

CIPO Patents = 1 (Patent Applications = 11)

EPO Patents = 15 (Patent Applications = 29)

Average Co-Inventor Count = 12.3

ph-index = 4

Forward Citations = 55(Granted Patents)

Company Filing History:

8 out of 12,269

Bayer Aktiengesellschaft

Elanco Animal Health Gmbh

patents

4. 1 out of 1

Bayal Animal Health Gmbh

patent

5. 1 out of 271

Bayer Cropscience Gmbh

patents

6. 1 out of 721

Bayer Intellectual Property Gmbh

patents

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Heteroaryl-Triazole Compounds

Pyrazolopyrimidine Derivatives

Insecticides

Acaricides

Haloalky-Substituted Amides

Aminopyrimidinamides

Bi-Phenyl-Amidine Derivatives

Acetylcholine Receptor Subunits

Heteroaryl-Substituted Compounds

Alpha-Beta-Unsaturated Imines

Heteroaryl-Tetrazole Compounds

9-Ketospinosyn Derivatives

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653190 - Heteroaryl-triazole compounds as pesticides (2026-06-16),

2. 12612386 - Heteroaryl-triazole compounds as pesticides (2026-04-28),

3. 12610949 - Heteroaryl-triazole compounds as pesticides (2026-04-28),

4. 12583851 - Heteroaryl-substituted pyrazine derivatives as pesticides (2026-03-24),

5. 12384769 - Heteroaryl-substituted aminoalkyl azole compounds as pesticides (2025-08-12),

6. 12187705 - Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides (2025-01-07),

7. 12171229 - Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides (2024-12-24),

8. 12116357 - Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides (2024-10-15),

9. 11864557 - Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides (2024-01-09),

10. 11528907 - Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides (2022-12-20),

11. 10604525 - Pyrazolopyrimidine derivatives (2020-03-31),

12. 9055743 - Alpha, beta-unsaturated imines (2015-06-16),

13. 8946234 - Halogen-substituted compounds (2015-02-03),

14. 8889878 - Haloalky-substituted amides as insecticides and acaricides (2014-11-18),

15. 8710242 - Haloalky -substituted amides as insecticides and acaricides (2014-04-29),

Title: Ulrich Ebbinghaus-Kintscher: Pioneering Inventor in Medical Technology

Introduction:

Ulrich Ebbinghaus-Kintscher, based in Dortmund, DE, is a distinguished inventor with a remarkable passion for innovation, particularly in the field of medical technology. His commitment to advancing healthcare has cemented his reputation as a pioneering figure in the industry.

Latest Patents:

Ebbinghaus-Kintscher holds an impressive portfolio of 11 patents, including his latest groundbreaking inventions. One of his recent patents is for "Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides," which focuses on novel compounds for controlling animal pests and ectoparasites, showcasing his versatility in invention.

Career Highlights:

Throughout his career, Ebbinghaus-Kintscher has been associated with prominent companies like Bayer CropScience AG and Bayer Aktiengesellschaft. His innovative spirit and dedication to improving healthcare have driven his success in creating impactful solutions through patent-protected inventions.

Collaborations:

In his professional journey, Ebbinghaus-Kintscher has collaborated with esteemed colleagues such as Arnd Voerste and Peter Jeschke. These collaborations have not only enriched his work but have also contributed to the development of revolutionary inventions in the realm of medical technology.

Conclusion:

Ulrich Ebbinghaus-Kintscher's relentless pursuit of innovation and his unwavering commitment to enhancing healthcare through inventive solutions have solidified his position as a trailblazing inventor in the field of medical technology. His patents stand as testaments to his creativity and dedication to making a meaningful impact in improving global health outcomes.

Profile summary based on public USPTO records.